| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-07 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-07 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.24 | 4e-07 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.21 | 7e-07 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.19 | 7e-07 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.21 | 8e-07 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.2 | 9e-07 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-06 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-06 |